| Literature DB >> 31030598 |
Veerle R Smaardijk1, Paul Lodder1,2, Willem J Kop1, Bente van Gennep1, Angela H E M Maas3, Paula M C Mommersteeg1.
Abstract
Background Psychological factors are associated with an increased risk of developing ischemic heart disease ( IHD ). Women more often report psychological factors, and sex and gender differences are present in IHD . In this meta-analysis we examine the risks of psychological factors for IHD incidence in women and men. We hypothesize that a broad range of psychological factors are related to a higher risk for incident IHD , with a higher risk for women. Methods and Results PubMed, EMBASE , and Psyc INFO were searched for studies assessing the risk between psychological factors and incident IHD . Psychological factors included depression, anxiety or panic disorder, social support, hostility, anger, personality (type D), type A behavior pattern, posttraumatic stress disorder, and psychological distress. In the primary analyses, 62 studies (77 separate reports) that included 2 145 679 women and 3 119 879 men and reported confounder-adjusted hazard ratios or relative risks were included. Pooled effect confounder-adjusted estimates from random-effects models showed that psychological factors (all combined) were associated with incident IHD in women (hazard ratio: 1.22; 95% CI , 1.14-1.30) and men (hazard ratio: 1.25; 95% CI , 1.19-1.31). No sex and gender differences were found for these pooled effect estimates ( P=0.547). Conclusions Psychological factors are associated with incident IHD in both women and men, but no significant differences were observed between women and men. IHD is predominantly being studied as obstructive coronary artery disease, which is more prevalent in men. Data are needed on psychological predictors and other manifestations of IHD such as coronary microvascular disease, which is more common in women.Entities:
Keywords: gender; incidence; ischemic heart disease; meta‐analysis; psychology and behavior; sex
Mesh:
Year: 2019 PMID: 31030598 PMCID: PMC6512085 DOI: 10.1161/JAHA.118.010859
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Flow chart of study selection. IHD indicates ischemic heart disease; S&G, sex and gender.
Characteristics of Studies Included in Our Primary Analyses
| First Author (Year) | Global Continent | Analyzed (n) | Baseline IHD Free | Age, y | S&G | % W | % European Descent | Q or D | Outcome | Adj. for Lifestyle | S&G in Study |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anger | |||||||||||
| Boyle (2006) | North America | 2105 | Yes | 46.7 | M | 0 | 94 | Q | IHD | Yes | Yes |
| Chang (2002) | North America | 1055 | Yes | 26.4 | M | 0 | 98 | Q | IHD | Yes | Yes |
| Eng (2003) | North America | 23 522 | Yes | 61.9 | M | 0 | NR | Q | IHD | Yes | Yes |
| Haukkala (2010) | Europe | 7368 | Yes | 46.9 | WM | 53 | NR | Q | IHD | Yes | Yes |
| Kubzansky (2006) | North America | 1306 | Yes | 61.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Player (2007) | North America | 2334 | Yes | NR | WM | 52 | 80 | Q | IHD | Yes | Yes |
| Stürmer (2006) | Europe | 3892 | Yes | 53.4 | WM | 52 | NR | Q | MI | Yes | No |
| Anxiety | |||||||||||
| Albert (2005) | North America | 72 359 | Yes | 54.4 | W | 100 | NR | Q | MI | Yes | Yes |
| Berge (2016) | Europe | 7052 | Yes | 43.1 | WM | 48 | NR | Q | IHD | Yes | Yes |
| Boyle (2006) | North America | 2105 | Yes | 46.7 | M | 0 | 94 | Q | IHD | Yes | Yes |
| Carriere (2013) | Europe | 1708 | No | NR | WM | 59 | NR | D | CM | Yes | Yes |
| Denollet (2009) | Europe | 5073 | Yes | 50.4 | W | 100 | 100 | Q | CM | Yes | Yes |
| Gustad (2014) | Europe | 57 953 | Yes | 47.7 | WM | 54 | NR | Q | MI | Yes | No |
| Janszky (2010) | Europe | 49 321 | Yes | NR | M | 0 | NR | D | IHD | Yes | Yes |
| Kubzansky (2006) | North America | 1306 | Yes | 61.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Mathur (2016) | Europe | 524 952 | Yes | 35.9 | WM | 47 | 42 | D | MI | Yes | No |
| Nefs (2015) | Europe | 961 | Yes | 67.0 | WM | 53 | 98 | Q | CVD | No | No |
| Phillips (2009) | North America | 4256 | NR | 39.1 | M | 0 | 82 | D | CM | Yes | Yes |
| Ringbäck (2005) | Europe | 34 511 | NR | 42.6 | WM | 50 | NR | Q | IHD | Yes | Yes |
| Smoller (2007) | North America | 3243 | No | 65.9 | W | 100 | 73 | Q | IHD | Yes | Yes |
| Stewart (2016) | North America | 2041 | Yes | 68.5 | WM | 73 | 42 | Q | MI | Yes | No |
| Depression | |||||||||||
| Ahto (2007) | Europe | 660 | Yes | 71.4 | WM | 57 | NR | Q | CM | No | Yes |
| Boyle (2006) | North America | 2105 | Yes | 46.7 | M | 0 | 94 | Q | IHD | Yes | Yes |
| Brunner (2014) | Europe | 5717 | Yes | 61.0 | WM | 29 | 93 | Q | CM/MI | No | No |
| Chi (2014) | Asia | 13 209 | Yes | NR | WM | 63 | NR | D | MI | No | Yes |
| Clouse (2003) | North America | 76 | Yes | 41.3 | W | 100 | 58 | D | IHD | Yes | Yes |
| Cohen (2001) | North America | 5564 | Yes | 53.2 | WM | 36 | 34 | Q | IHD | Yes | Yes |
| Daskalopoulou (2016) | Europe | 1 233 937 | Yes | 47.3 | WM | 49 | NR | D | MI | Yes | Yes |
| Ferketich (2000) | North America | 7903 | Yes | 54.5 | WM | 63 | 86 | Q | IHD | Yes | Yes |
| Gale (2014) | Europe | 1 107 524 | Yes | 18.3 | M | 0 | NR | D | IHD | No | Yes |
| Gasse (2014) | Europe | 4 545 327 | Yes | NR | WM | NR | NR | D | IHD | No | Yes |
| Gump (2005) | North America | 11 216 | Yes | 46.4 | M | 0 | 90 | Q | CM | Yes | Yes |
| Gustad (2014) | Europe | 57 953 | Yes | 47.7 | WM | 54 | NR | Q | MI | Yes | No |
| Haukkala (2009) | Europe | 7674 | Yes | 47.7 | WM | 52 | NR | Q | IHD | Yes | Yes |
| Hiles (2015) | Oceania | 1692 | Yes | 65.2 | WM | 53 | NR | Q | CVD | NR | No |
| Hiltunen (2014) | Europe | 508 | NR | 80.2 | WM | 73 | NR | Q | CM | No | No |
| Huang (2013) | Asia | 39 685 | Yes | NR | WM | 63 | NR | D | IHD | Yes | No |
| Janszky (2010) | Europe | 49 321 | Yes | NR | M | 0 | NR | D | IHD | Yes | Yes |
| Kamphuis (2006) | Europe | 799 | Yes | 76.3 | M | 0 | NR | Q | CM | Yes | Yes |
| Kendler (2009) | Europe | 27 517 | Yes | 57.3 | WM | 53 | NR | Q | IHD | No | Yes |
| Khambaty (2016) | North America | 26 144 | Yes | 48.0 | WM | 3 | 38 | D | MI | Yes | No |
| Klabbers (2009) | Europe | 2374 | Yes | 41.9 | WM | 51 | NR | Q | IHD | No | Yes |
| Kubzansky (2006) | North America | 1306 | Yes | 61.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Liu (2016) | Asia | 486 541 | Yes | 51.0 | WM | 59 | NR | D | IHD | Yes | No |
| Majed (2012) | Europe | 9601 | Yes | 54.9 | M | 0 | NR | Q | IHD | Yes | Yes |
| Mallon (2002) | Europe | 1870 | No | 56.0 | WM | 52 | NR | Q | CM | Yes | Yes |
| Mathur (2016) | Europe | 524 952 | Yes | 35.9 | WM | 47 | 42 | D | MI | Yes | No |
| Mejía‐Lancheros (2014) | Europe | 7263 | Yes | 67.0 | WM | 58 | NR | D | CVD | Yes | Yes |
| Nefs (2015) | Europe | 961 | Yes | 67.0 | WM | 53 | 98 | Q | CVD | No | No |
| Phillips (2009) | North America | 4256 | NR | 39.1 | M | 0 | 82 | D | CM | Yes | Yes |
| Shah (2011) | North America | 7641 | Yes | 28.1 | WM | 54 | 29 | D | CM | Yes | Yes |
| Stürmer (2006) | Europe | 3892 | Yes | 53.4 | WM | 52 | NR | Q | MI | Yes | No |
| Sun (2013) | Asia | 62 839 | NR | NR | WM | 66 | NR | Q | CM | Yes | Yes |
| Sundquist (2005) | Europe | NR | NR | NR | WM | NR | NR | D | IHD | No | Yes |
| Surtees (2008) | Europe | 19 649 | Yes | NR | WM | 58 | NR | Q | CM | Yes | Yes |
| Wassertheil‐Smoller (2004) | North America | 73 098 | Yes | NR | W | 100 | 83 | Q | IHD | Yes | Yes |
| Whang (2009) | North America | 63 469 | Yes | 58.4 | W | 100 | NR | Q | MI | Yes | Yes |
| Yasuda (2002) | Asia | 817 | Yes | 72.0 | WM | 61 | NR | Q | CM | Yes | Yes |
| Distress | |||||||||||
| Gustad (2014) | Europe | 57 953 | Yes | 47.7 | WM | 54 | NR | Q | MI | Yes | No |
| Kubzansky (2006) | North America | 1306 | Yes | 61.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Macleod (2002) | Europe | 5606 | No | 48.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Nicholson (2005) | Europe | 5075 | Yes | 49.2 | M | 0 | NR | Q | IHD | Yes | Yes |
| Nielsen (2008) | Europe | 12 128 | No | 56.5 | WM | 55 | NR | Q | CM | Yes | Yes |
| Ohlin (2004) | Europe | 13 280 | Yes | 45.2 | WM | 20 | NR | Q | IHD | Yes | Yes |
| Player (2007) | North America | 2334 | Yes | NR | WM | 52 | 80 | Q | IHD | Yes | Yes |
| Rasul (2005) | Europe | 6575 | Yes | 54.5 | WM | 55 | NR | Q | IHD | No | Yes |
| Rasul (2007) | Europe | 1864 | Yes | 57.4 | M | 0 | NR | Q | MI | Yes | Yes |
| Hostility | |||||||||||
| Boyle (2006) | North America | 2105 | Yes | 46.7 | M | 0 | 94 | Q | IHD | Yes | Yes |
| Klabbers (2009) | Europe | 2374 | Yes | 41.9 | WM | 51 | NR | Q | IHD | No | Yes |
| Tindle (2009) | North America | 97 253 | Yes | NR | W | 100 | 92 | Q | IHD | Yes | Yes |
| PTSD | |||||||||||
| Boscarino (2008) | North America | 4328 | Yes | 38.0 | M | 0 | 82 | D | CM | Yes | Yes |
| Jordan (2013) | North America | 46 346 | Yes | 41.1 | WM | 40 | 56 | Q | IHD | Yes | Yes |
| Low social support | |||||||||||
| De Vogli (2007) | Europe | 8499 | Yes | 44.3 | WM | 32 | NR | Q | IHD | Yes | No |
| Ikeda (2008) | Asia | 44 152 | Yes | 53.6 | WM | 52 | NR | Q | IHD | Yes | Yes |
| Kuper (2006) | Europe | 48 066 | Yes | 40.3 | W | 100 | NR | Q | IHD | Yes | Yes |
| Rosengren (2004) | Europe | 741 | Yes | 50.0 | M | 0 | NR | Q | IHD | Yes | Yes |
| Type A behavior | |||||||||||
| Lohse (2017) | Europe | 9921 | NR | 43.6 | WM | 51 | NR | Q | CM | Yes | Yes |
Adj. indicates adjusted; CM, cardiac mortality; CVD, cardiovascular disease; D, diagnosis; IHD, ischemic heart disease; M, men; MI, myocardial infarction; NR, not reported; PTSD, posttraumatic stress disorder; Q, questionnaire; S&G, sex and gender; W, women; WM, women and men.
Numbers (1, 2, 3, etc) after the reference indicate the separate study reports of the study.
Figure 2Forest plot showing individual and overall effect size estimates with 95% CIs for psychological factors and incident IHD in women (adjusted findings). Includes reports from the following studies: ‡ HR indicates hazard ratio; PTSD, posttraumatic stress disorder; Q, Cochran Q statistic.
Figure 3Forest plot showing individual and overall effect size estimates with 95% CIs for psychological factors and incident IHD in men (adjusted findings). Includes reports from the following studies: § HR indicates hazard ratio; PTSD, posttraumatic stress disorder; Q, Cochran Q statistic.
S&G‐Stratified Analyses of HRs and Relative Risks for Incident IHD Associated With Psychological Factors: Adjusted Findings
| Variable | Women | Men |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | HR (95% CI) |
| Q |
| I2, % | n | HR (95% CI) |
| Q |
| I2, % | ||
| Anger | 3 | 1.29 (0.49–3.43) | 0.610 | 3.44 | 0.179 | 41.9 | 7 | 1.27 (1.05–1.53) | 0.012 | 10.3 | 0.114 | 41.6 | 0.974 |
| Anxiety | 10 | 1.29 (1.03–1.60) | 0.024 | 31.2 | <0.001 | 71.2 | 9 | 1.42 (1.19–1.69) | 0.001 | 27.9 | 0.001 | 71.3 | 0.491 |
| Depression | 28 | 1.24 (1.15–1.33) | <0.001 | 84.3 | <0.001 | 68.0 | 34 | 1.23 (1.16–1.31) | <0.001 | 94.4 | <0.001 | 65.0 | 0.898 |
| Distress | 5 | 1.31 (1.08–1.58) | 0.005 | 3.21 | 0.524 | 0 | 9 | 1.35 (1.15–1.59) | <0.001 | 18.4 | 0.018 | 56.6 | 0.798 |
| Hostility | 2 | 1.52 (0.59–3.91) | 0.385 | 4.21 | 0.040 | 76.2 | 2 | 1.17 (1.03–1.34) | 0.019 | 0.52 | 0.470 | 0 | 0.595 |
| PTSD | 1 | ··· | ··· | ··· | ··· | ··· | 2 | 1.37 (0.91–2.06) | 0.133 | 1.46 | 0.228 | 31.3 | ··· |
| Low social support | 3 | 0.89 (0.61–1.31) | 0.555 | 3.57 | 0.167 | 44.0 | 3 | 1.21 (0.92–1.60) | 0.178 | 3.46 | 0.177 | 42.2 | 0.192 |
| Type A behavior | 1 | ··· | ··· | ··· | ··· | ··· | 1 | ··· | ··· | ··· | ··· | ··· | ··· |
| Type D personality | 0 | ··· | ··· | ··· | ··· | ··· | 0 | ··· | ··· | ··· | ··· | ··· | ··· |
| Psychological combined | 53 | 1.22 (1.14–1.30) | <0.001 | 146.6 | <0.001 | 64.5 | 67 | 1.25 (1.19–1.31) | <0.001 | 165.2 | <0.001 | 60.1 | 0.547 |
HR indicates hazard ratio; IHD, ischemic heart disease; P between, P value between groups (women and men); P het, P value for heterogeneity; PTSD, posttraumatic stress disorder; Q, Cochran Q statistic; S&G, sex and gender.
S&G‐Stratified Analyses of HRs and Relative Risks for Incident IHD Associated With Psychological Factors by Subgroup: Adjusted Findings
| Variable | Women | Men | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | HR (95% CI) | Q |
| I2, % |
| n | HR (95% CI) | Q |
| I2, % |
| |
| Follow‐up, y | 0.521 | 0.002 | ||||||||||
| <11 | 32 | 1.22 (1.12–1.32) | 55.0 | <0.001 | 55.0 | 34 | 1.35 (1.24–1.48) | 72.8 | <0.001 | 55.0 | ||
| ≥11 | 17 | 1.17 (1.06–1.28) | 44.3 | <0.001 | 63.9 | 29 | 1.16 (1.11–1.21) | 43.4 | 0.032 | 35.5 | ||
| Global continent | 0.496 | 0.118 | ||||||||||
| Europe | 32 | 1.24 (1.15–1.34) | 81.4 | <0.001 | 61.9 | 38 | 1.20 (1.13–1.27) | 102.6 | <0.001 | 63.9 | ||
| North America | 14 | 1.29 (1.10–1.52) | 47.1 | <0.001 | 72.4 | 22 | 1.33 (1.22–1.45) | 46.6 | 0.001 | 54.9 | ||
| Asia | 6 | 1.13 (0.99–1.29) | 8.48 | 0.132 | 41.0 | 6 | 1.32 (1.16–1.50) | 6.81 | 0.235 | 26.6 | ||
| Oceania | 1 | ··· | ··· | ··· | ··· | 1 | ··· | ··· | ··· | ··· | ||
| No. of people analyzed | 0.057 | 0.025 | ||||||||||
| <5000 | 16 | 1.48 (1.17–1.86) | 31.6 | 0.007 | 52.6 | 28 | 1.35 (1.23–1.48) | 72.8 | <0.001 | 62.9 | ||
| ≥5000 | 36 | 1.17 (1.10–1.24) | 71.5 | <0.001 | 51.0 | 38 | 1.20 (1.14–1.26) | 62.5 | 0.006 | 40.8 | ||
| Age, y | 0.770 | 0.062 | ||||||||||
| <60 | 32 | 1.26 (1.14–1.39) | 66.7 | <0.001 | 53.5 | 43 | 1.19 (1.14–1.24) | 49.5 | 0.199 | 15.2 | ||
| 60–65 | 2 | 1.77 (0.69–4.49) | 0.07 | 0.789 | 0 | 7 | 1.74 (1.20–2.51) | 24.0 | <0.001 | 75.0 | ||
| >65 | 8 | 1.24 (0.97–1.58) | 19.4 | 0.007 | 63.8 | 7 | 1.09 (0.96–1.25) | 6.69 | 0.351 | 10.3 | ||
| European descent | 0.960 | 0.756 | ||||||||||
| <50% | 6 | 1.39 (1.09–1.77) | 12.0 | 0.035 | 58.3 | 6 | 1.18 (1.02–1.36) | 7.48 | 0.187 | 33.2 | ||
| ≥50% | 12 | 1.40 (1.13–1.74) | 29.9 | 0.002 | 63.3 | 15 | 1.21 (1.15–1.27) | 14.6 | 0.406 | 4.14 | ||
| Type of measurement | 0.650 | 0.676 | ||||||||||
| Questionnaire | 40 | 1.20 (1.11–1.30) | 78.7 | <0.001 | 50.4 | 50 | 1.23 (1.19–1.33) | 109.1 | <0.001 | 55.1 | ||
| Diagnosis by a clinical interview | 13 | 1.24 (1.11–1.38) | 53.2 | <0.001 | 77.4 | 17 | 1.23 (1.14–1.34) | 48.6 | <0.001 | 67.1 | ||
| Adjusted for lifestyle | 0.954 | 0.373 | ||||||||||
| No | 12 | 1.23 (1.10–1.36) | 51.5 | <0.001 | 78.6 | 12 | 1.20 (1.09–1.32) | 57.3 | <0.001 | 80.8 | ||
| Yes | 40 | 1.23 (1.13–1.34) | 92.1 | <0.001 | 57.7 | 54 | 1.27 (1.20–1.34) | 103.2 | <0.001 | 48.7 | ||
| Baseline free of IHD | 0.158 | 0.958 | ||||||||||
| No | 3 | 1.90 (0.99–3.66) | 6.33 | 0.042 | 68.4 | 3 | 1.25 (0.86–1.80) | 4.70 | 0.095 | 57.5 | ||
| Yes | 44 | 1.19 (1.12–1.26) | 87.5 | <0.001 | 50.9 | 56 | 1.23 (1.18–1.29) | 116.1 | <0.001 | 52.6 | ||
| S&G‐stratified results in study | 0.209 | 0.347 | ||||||||||
| No | 17 | 1.28 (1.19–1.39) | 9.60 | 0.887 | 0 | 16 | 1.20 (1.11–1.31) | 18.1 | 0.258 | 17.0 | ||
| Yes | 36 | 1.20 (1.11–1.29) | 130.8 | <0.001 | 73.3 | 51 | 1.26 (1.20–1.33) | 147.0 | <0.001 | 66.0 | ||
| Publication year | 0.814 | 0.066 | ||||||||||
| <2010 | 28 | 1.23 (1.11–1.38) | 111.7 | <0.001 | 75.8 | 40 | 1.30 (1.21–1.39) | 124.8 | <0.001 | 68.7 | ||
| ≥2010 | 25 | 1.22 (1.14–1.30) | 34.9 | 0.070 | 31.2 | 27 | 1.19 (1.12–1.27) | 39.1 | 0.05 | 33.6 | ||
| IHD outcome | 0.482 | 0.186 | ||||||||||
| CM | 19 | 1.34 (1.14–1.57) | 134.1 | <0.001 | 86.6 | 24 | 1.37 (1.19–1.57) | 112.8 | <0.001 | 79.6 | ||
| IHD | 29 | 1.24 (1.13–1.37) | 91.6 | <0.001 | 69.4 | 40 | 1.28 (1.21–1.35) | 94.9 | <0.001 | 58.9 | ||
| MI | 18 | 1.20 (1.10–1.31) | 38.2 | 0.002 | 55.5 | 23 | 1.19 (1.09–1.30) | 42.2 | 0.006 | 47.9 | ||
| Sample | 0.838 | |||||||||||
| Community | 40 | 1.22 (1.14–1.30) | 110.5 | <0.001 | 64.7 | 50 | 1.25 (1.18–1.33) | 146.6 | <0.001 | 66.6 | 0.605 | |
| High risk | 9 | 1.34 (0.88–2.05) | 16.1 | 0.040 | 50.4 | 8 | 1.26 (1.13–1.39) | 6.86 | 0.443 | 0 | ||
| Military sample | ··· | ··· | ··· | ··· | ··· | 9 | 1.20 (1.13–1.28) | 10.2 | 0.249 | 21.8 | ||
| Menopausal | 4 | 1.29 (0.99–1.68) | 14.7 | 0.002 | 79.6 | ··· | ··· | ··· | ··· | ··· | ||
CM indicates cardiac mortality; HR, hazard ratio; IHD, ischemic heart disease; MI, myocardial infarction; P between, P value between groups; P het, P value for heterogeneity; Q, Cochran Q statistic; S&G, sex and gender.
Includes additional reports from the following studies:‖
Figure 4Funnel plot of studies focusing on women (white dots) and studies imputed according to the trim and fill method (black dots). The pooled hazard ratio (HR) of included studies (HR: 1.22; 95% CI, 1.14–1.30) decreases after imputing studies (HR: 1.18; 95% CI, 1.10–1.26).
Figure 5Funnel plot of studies focusing on men (white dots) and studies imputed according to the trim and fill method (black dots). The pooled hazard ratio (HR) of included studies (HR: 1.25; 95% CI, 1.19–1.31) decreases after imputing studies (HR: 1.20; 95% CI, 1.14–1.26).